<!doctype html>
<html lang="en">

<head>
  <!-- Required meta tags -->
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <!-- Bootstrap CSS -->
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/css/bootstrap.min.css" integrity="sha384-9aIt2nRpC12Uk9gS9baDl411NQApFmC26EwAOH8WgZl5MYYxFfc+NcPb1dKGj7Sk" crossorigin="anonymous">

  <!-- Other CSS -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
  <link rel="stylesheet" href="bchu.css">
  <link rel="icon" href="images/penn-favicon.png" type="image/x-icon">
  <title>Abdominal Infections</title>
</head>


<body>

  <header class="header-penn">
    <!-- NAVBAR -->
    <nav class="navbar navbar-expand-lg navbar-dark bg-dark navbar-penn">
      <a class="navbar-brand logo-penn" href="#">
        <img src="images/penn-shield.png" width="30" height="30" class="d-inline-block align-center">
        Antimicrobial Stewardship
      </a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>
      <div class="collapse navbar-collapse" id="navbarNav">
        <ul class="navbar-nav">
          <li class="nav-item">
            <a class="nav-link" href="#">Home <span class="sr-only">(current)</span></a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Microbiology (Bugdrug)</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">ID Transition Service (IDTS)</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Infection Control</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Education</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Contact Us</a>
          </li>
        </ul>
      </div>
    </nav>

    <!--    <h1>Abdominal Infection Guidelines</h1>-->
  </header>

  <div class="container">
    <div class="row">
      <aside class="col-12 col-lg-3">
        <div class="nav-div-penn">

          <!-- SIDEBAR, changes position when small -->
          <nav class="nav flex-column nav-penn">
            <a class="nav-link" href="#">ilum</a>
            <a class="nav-link" href="#">Antibiotic Approval</a>
            <div class="dropdown show">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Treatment Guidelines</a>
              <div class="dropdown-menu">
                <a class="dropdown-item" href="#">Action</a>
                <a class="dropdown-item" href="#">Another action</a>
                <a class="dropdown-item" href="#">Something else here</a>
                <div class="dropdown-divider"></div>
                <a class="dropdown-item" href="#">Separated link</a>
              </div>
            </div>
            <a class="nav-link" href="#">Prophylaxis Guidelines</a>
            <a class="nav-link" href="#">Antimicrobial Dosing</a>
            <a class="nav-link" href="#">Antimicrobial Information</a>
            <a class="nav-link" href="#">Antimicrobial Formulary</a>
          </nav>

        </div>
      </aside>
      <!-- article contains the accordion, CSS means 12 mobile, 9 when lg -->
      <article class="col-12 col-lg-9">
        <h1>Abdominal Infection Guidelines</h1>

        <!--  No formatting test  -->
        <!--
    <div>
      <h2>Intra-abdominal infection</h2>

      <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see link on Dosing of Antimicrobial Agents.</p>
      <p>An appropriate source control procedure to drain infected foci, control ongoing peritoneal contamination by diversion or resection, and restore anatomic and physiological function to the extent feasible is recommended for nearly all patients with intra-abdominal infection.</p>
      <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
      <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

      <table class="table table-bordered">
        <thead class="thead-dark">
          <tr>
            <th scope="col">Setting</th>
            <th scope="col">Preferred Therapy</th>
            <th scope="col">B-Lactam Allergy</th>
            <th scope="col">Antifungal Therapy</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="4">Community-Acquired <br>
              Hospitalized &lt; 48 hours <br>
              Organisms:
              Enterobacteriaceae
              Streptococcus spp.
              Anaerobes </td>
          </tr>
          <tr>
            <th scope="row">Low risk/severity</th>
            <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
            <td rowspan="2">Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
          </tr>
          <tr>
            <th scope="row">High risk</th>
            <td>Preferred: Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg IV/PO Q12H <br> Alternative: Piperacillin-tazobactam 4.5 grams IV Q8H</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
          </tr>
          <tr>
            <th scope="row">High severity (sepsis/septic shock)</th>
            <td colspan="3">See sepsis/septic shock guidelines</td>
          </tr>
          <tr>
            <td colspan="4">Healthcare-Associated <br> Hospitalized ≥ 48 hours, Post-operative <br> Organisms: Pseudomonas aeruginosa
              Enterobacteriaceae
              Staphylococcus aureus
              Enterococcus spp.
              Anaerobes +/-
              Candida spp.</td>
          </tr>
          <tr>
            <th scope="row">Mild to moderate severity</th>
            <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
            <td>Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
          </tr>
          <tr>
            <th scope="row">High severity (sepsis/septic shock)</th>
            <td colspan="3">See sepsis/septic shock guidelines</td>
          </tr>
        </tbody>
      </table>

      <h2>Cholecystitis and Cholangitis</h2>

      <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see link on Dosing of Antimicrobial Agents.</p>
      <p>Antimicrobial therapy should be initiated only in patients that fall into the appropriate categories below.</p>
      <p>An appropriate source control procedure is essential to success of treatment (e.g. cholecystostomy, biliary stent, gallstone removal, etc.).</p>
      <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
      <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

      <table class="table table-bordered">
        <thead class="thead-dark">
          <tr>
            <th scope="col">Setting</th>
            <th scope="col">Preferred Therapy</th>
            <th scope="col">B-Lactam Allergy</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="3">Community-acquired acute cholecystitis <br>
              Hospitalized &lt; 48 hours <br>
              Organisms:
              Enterobacteriaceae
              Streptococcus spp. +/-
              Anaerobes </td>
          </tr>
          <tr>
            <th scope="row">No signs or symptoms of infection (WBC ≤ 12.5, temperature ≤ 38.5 °C, no radiographic signs of rupture, abscess, or gas)</th>
            <td colspan="2">No antibiotics necessary.</td>
          </tr>
          <tr>
            <th scope="row">Mild to moderate severity</th>
            <td>Ceftriaxone 1 gram IV daily</td>
            <td>Levofloxacin 500 mg IV/PO daily</td>
          </tr>
          <tr>
            <th scope="row">High risk (Advanced age, immunocompromised1)</th>
            <td>Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg IV/PO Q12H <br> Alternative: Piperacillin-tazobactam 4.5 grams IV Q8H</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
          </tr>
          <tr>
            <th scope="row">High severity (sepsis/septic shock)</th>
            <td colspan="2">See sepsis/septic shock guidelines</td>
          </tr>
          <tr>
            <td colspan="3">Community-acquired cholangitis <br> Hospitalized &lt; 48 hours <br>
              Organisms:
              Enterobacteriaceae
              Streptococcus spp.</td>
          </tr>
          <tr>
            <th scope="row">All</th>
            <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
          </tr>
          <tr>
            <td colspan="3">Healthcare-associated biliary infection <br> Hospitalized ≥ 48 hours, Post-operative <br>
              Organisms:
              Pseudomonas aeruginosa
              Enterobacteriaceae
              Staphylococcus aureus
              Streptococcus spp.
              Enterococcus spp.
              Anaerobes</td>
          </tr>
          <tr>
            <th scope="row">Non-sepsis</th>
            <td>Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg PO Q12H AND Vancomycin IV (dosing link) <br>
              Option 2: Piperacillin/tazobactam 4.5 grams IV Q8H AND Vancomycin IV (dosing link)</td>
            <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H AND Vancomycin IV</td>
          </tr>
          <tr>
            <th scope="row">Sepsis/septic shock</th>
            <td colspan="2">(See Sepsis/Septic Shock Guidelines)</td>
          </tr>
        </tbody>
      </table>

      <h2>References</h2>
      <ul>
        <li>Reference</li>
        <li>Reference</li>
        <li>Reference</li>
        <li>Reference</li>
      </ul>
    </div> -->

        <!-- accordion -->
        <div class="accordion" id="abdominal">
          <div class="card">
            <div class="card-header" id="headingOne">
              <h2 class="mb-0">
                <button class="btn btn-link btn-penn" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne"><i class="fa fa-plus"></i>
                  Intra-abdominal infection
                </button>
              </h2>
            </div>
            <!--  To show by default, add "show" to the class of id=collapseOne  -->
            <div id="collapseOne" class="collapse" aria-labelledby="headingOne" data-parent="">
              <div class="card-body">

                <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see link on Dosing of Antimicrobial Agents.</p>
                <p>An appropriate source control procedure to drain infected foci, control ongoing peritoneal contamination by diversion or resection, and restore anatomic and physiological function to the extent feasible is recommended for nearly all patients with intra-abdominal infection.</p>
                <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
                <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

                <table class="table table-bordered table-sm table-responsive table-penn">
                  <thead class="thead-dark">
                    <tr>
                      <th scope="col">Setting</th>
                      <th scope="col">Preferred Therapy</th>
                      <th scope="col">B-Lactam Allergy</th>
                      <th scope="col">Antifungal Therapy</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr class="tr-penn">
                      <td colspan="4"><strong>Community-Acquired</strong> <br>
                        Hospitalized &lt; 48 hours <br>
                        Organisms:
                        Enterobacteriaceae
                        Streptococcus spp.
                        Anaerobes </td>
                    </tr>
                    <tr>
                      <th scope="row">Low risk/severity</th>
                      <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
                      <td rowspan="2">Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
                    </tr>
                    <tr>
                      <th scope="row">High risk</th>
                      <td>Preferred: Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg IV/PO Q12H <br> Alternative: Piperacillin-tazobactam 4.5 grams IV Q8H</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity (sepsis/septic shock)</th>
                      <td colspan="3">See sepsis/septic shock guidelines</td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="4">Healthcare-Associated <br> Hospitalized ≥ 48 hours, Post-operative <br> Organisms: Pseudomonas aeruginosa
                        Enterobacteriaceae
                        Staphylococcus aureus
                        Enterococcus spp.
                        Anaerobes +/-
                        Candida spp.</td>
                    </tr>
                    <tr>
                      <th scope="row">Mild to moderate severity</th>
                      <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
                      <td>Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity (sepsis/septic shock)</th>
                      <td colspan="3">See sepsis/septic shock guidelines</td>
                    </tr>
                  </tbody>
                </table>

              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingTwo">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo"><i class="fa fa-plus"></i>
                  Cholecystitis and Cholangitis
                </button>
              </h2>
            </div>
            <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="">
              <div class="card-body">
                <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see link on Dosing of Antimicrobial Agents.</p>
                <p>Antimicrobial therapy should be initiated only in patients that fall into the appropriate categories below.</p>
                <p>An appropriate source control procedure is essential to success of treatment (e.g. cholecystostomy, biliary stent, gallstone removal, etc.).</p>
                <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
                <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

                <table class="table table-bordered table-sm table-responsive table-penn">
                  <thead class="thead-dark">
                    <tr>
                      <th scope="col">Setting</th>
                      <th scope="col">Preferred Therapy</th>
                      <th scope="col">B-Lactam Allergy</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td colspan="3" class="tr-penn">Community-acquired acute cholecystitis <br>
                        Hospitalized &lt; 48 hours <br>
                        Organisms:
                        Enterobacteriaceae
                        Streptococcus spp. +/-
                        Anaerobes </td>
                    </tr>
                    <tr>
                      <th scope="row">No signs or symptoms of infection (WBC ≤ 12.5, temperature ≤ 38.5 °C, no radiographic signs of rupture, abscess, or gas)</th>
                      <td colspan="2">No antibiotics necessary.</td>
                    </tr>
                    <tr>
                      <th scope="row">Mild to moderate severity</th>
                      <td>Ceftriaxone 1 gram IV daily</td>
                      <td>Levofloxacin 500 mg IV/PO daily</td>
                    </tr>
                    <tr>
                      <th scope="row">High risk (Advanced age, immunocompromised1)</th>
                      <td>Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg IV/PO Q12H <br> Alternative: Piperacillin-tazobactam 4.5 grams IV Q8H</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity (sepsis/septic shock)</th>
                      <td colspan="2">See sepsis/septic shock guidelines</td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="3">Community-acquired cholangitis <br> Hospitalized &lt; 48 hours <br>
                        Organisms:
                        Enterobacteriaceae
                        Streptococcus spp.</td>
                    </tr>
                    <tr>
                      <th scope="row">All</th>
                      <td>Preferred: Ceftriaxone 1 gram IV daily AND Metronidazole 500 mcg PO Q12H <br>Alternative: Ampicillin/sulbactam 1.5 grams IV Q6H</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H</td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="3">Healthcare-associated biliary infection <br> Hospitalized ≥ 48 hours, Post-operative <br>
                        Organisms:
                        Pseudomonas aeruginosa
                        Enterobacteriaceae
                        Staphylococcus aureus
                        Streptococcus spp.
                        Enterococcus spp.
                        Anaerobes</td>
                    </tr>
                    <tr>
                      <th scope="row">Non-sepsis</th>
                      <td>Option 1: Cefepime 1 gram IV Q8H AND Metronidazole 500 mg PO Q12H AND Vancomycin IV (dosing link) <br>
                        Option 2: Piperacillin/tazobactam 4.5 grams IV Q8H AND Vancomycin IV (dosing link)</td>
                      <td>Levofloxacin 750 mg IV/PO daily AND Metronidazole 500 mg PO Q12H AND Vancomycin IV</td>
                    </tr>
                    <tr>
                      <th scope="row">Sepsis/septic shock</th>
                      <td colspan="2">(See Sepsis/Septic Shock Guidelines)</td>
                    </tr>
                  </tbody>
                </table>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingThree">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree"><i class="fa fa-plus"></i>
                  References
                </button>
              </h2>
            </div>
            <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="">
              <div class="card-body">
                <ul>
                  <li>Reference</li>
                  <li>Reference</li>
                  <li>Reference</li>
                  <li>Reference</li>
                </ul>
              </div>
            </div>
          </div>
        </div>
        <br>
        <p>Last updated 4/1/2020</p>
      </article>
    </div>
  </div>




  <!-- Optional JavaScript -->
  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.min.js" integrity="sha384-OgVRvuATP1z7JjHLkuOU7Xw704+h835Lr+6QL9UvYjZE3Ipu6Tp75j7Bh/kR0JKI" crossorigin="anonymous"></script>
  <!-- Font Awesome icon script -->
  <script>
    $(document).ready(function() {
      // Add minus icon for collapse element which is open by default
      $(".collapse.show").each(function() {
        $(this).prev(".card-header").find(".fa").addClass("fa-minus").removeClass("fa-plus");
      });

      // Toggle plus minus icon on show hide of collapse element
      $(".collapse").on('show.bs.collapse', function() {
        $(this).prev(".card-header").find(".fa").removeClass("fa-plus").addClass("fa-minus");
      }).on('hide.bs.collapse', function() {
        $(this).prev(".card-header").find(".fa").removeClass("fa-minus").addClass("fa-plus");
      });
    });
  </script>
</body></html>
